Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2010
07/01/2010US20100167393 Modified human thymic stromal lymphopoietin
07/01/2010US20100167392 Factor viii compositions and methods
07/01/2010US20100167390 Novel Oligonucleotide and NF-kB Decoy Comprising the Same
07/01/2010US20100167357 Obligate heterodimer meganucleases and uses thereof
07/01/2010US20100167354 Methods and compositions for amplification of rna sequences
07/01/2010US20100167348 Peptide capable of binding to immunoglobulin
07/01/2010US20100167347 used to incorporate a selected amino acid in a specific position in a growing polypeptide chain (during nucleic acid translation) in response to a selector codon that is recognized by the tRNA
07/01/2010US20100167345 Halohydrin dehalogenases and related polynucleotides
07/01/2010US20100167344 Novel sialidases
07/01/2010US20100167343 Oviduct specific expression promoter and recombinant expression vector comprising the same
07/01/2010US20100167341 Novel protein expression system
07/01/2010US20100167333 Heavy Metal Binding Compounds and Their Method of Use
07/01/2010US20100167327 System for obfuscating identity
07/01/2010US20100167314 Control of intracellular target molecule by ip3 receptor-binding protein
07/01/2010US20100167311 Oxidoreductases and Processes Utilising Such Enzymes
07/01/2010US20100167299 Phospholink nucleotides for sequencing applications
07/01/2010US20100167298 PURO-DHFR Quadrifunctional Marker and its use in Protein Production
07/01/2010US20100167296 Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on egfr/csf-1/ca ix expression
07/01/2010US20100167293 Digital Assay
07/01/2010US20100167290 Molecule attachment to nanoparticles
07/01/2010US20100167280 Oligonucleotides for discriminating related nucleic acid sequences
07/01/2010US20100167270 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
07/01/2010US20100167040 Identification of a novel type of sucrose synthase and use thereof in fiber modification
07/01/2010US20100166842 Amphiphilic substances and functionalized lipid vesicles including the same
07/01/2010US20100166800 Recombinant attenuated clostridium organisms and vaccine
07/01/2010US20100166794 Plasmodium liver stage antigens
07/01/2010US20100166787 Vaccines and methods for using the same
07/01/2010US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof
07/01/2010US20100166784 Method and compositions for modulating th17 cell development
07/01/2010US20100166778 Toll-Like Receptor 3 Antagonists
07/01/2010US20100166772 ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
07/01/2010US20100166771 detecting NTHi bacteria in a biological sample using a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 599; vaccines and methods of treating and preventing NTHi related disorders such as NTHi infection of the middle ear and/or the nasopharynx
07/01/2010US20100166770 Antagonists of bacterial sequences
07/01/2010US20100166768 High Affinity Human Antibodies to PCSK9
07/01/2010US20100166767 Engineered anti-il-23r antibodies
07/01/2010US20100166766 Engineered anti-tslp antibody
07/01/2010US20100166758 Novel antibody molecules and nucleic acids
07/01/2010US20100166755 Anti-egfr antibodies
07/01/2010US20100166749 Polypeptide variants with altered effector function
07/01/2010US20100166748 C5 Antigens and Uses Thereof
07/01/2010US20100166741 Altered br-3 binding polypeptides
07/01/2010US20100166738 Compositions and methods for wt1 specific immunotherapy
07/01/2010US20100166736 Immunostimulatory oligonucleotide multimers
07/01/2010US20100166733 Mcp-1 splice variants and methods of using same
07/01/2010US20100166732 Small streptococcus pyogenes antigens and their use
07/01/2010US20100166723 Genes encoding nematode toxins
07/01/2010US20100166707 Extracellular matrix/metastasis modifier genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor
07/01/2010US20100166661 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION
07/01/2010US20100162622 Nucleic acid molecules and other molecules associated with the phosphogluconate pathway
07/01/2010CA2748034A1 Nucleoside analogs
07/01/2010CA2747999A1 Sulfurizing reagents and their use for oligonucleotides synthesis
06/2010
06/30/2010EP2202239A1 RNAI inhibition of influenza virus replication
06/30/2010EP2202238A1 Nucleotide Compounds including a rigid linker
06/30/2010EP1622648B1 Dna vaccines against tumor growth and methods of use thereof
06/30/2010CN101759739A Method for extracting ribonucleic acid from animal liver
06/30/2010CN101215611B Primer for detecting southern cowpea mosaic virus
06/29/2010US7745707 Plants and seeds of corn variety CV443328
06/29/2010US7745695 Generation of plants with altered oil content
06/29/2010US7745693 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same
06/29/2010US7745614 genetic probes modified at the 5' terminus by a functional group, which is linked to the nucleic acid through an activating leaving group and a tether, that provide for detectable or functional changes following their release from the modified nucleic acid; kits for detecting of nucleic acid sequences
06/29/2010US7745612 siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)
06/29/2010US7745611 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
06/29/2010US7745610 siRNA targeting cyclin dependent kinase 11 (CDK11)
06/29/2010US7745609 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents
06/29/2010US7745608 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs
06/29/2010US7745606 polynucleotides used for modulating immune responses; immunotherapy
06/29/2010US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
06/29/2010US7745602 a polynucleotide and a genetic vector comprising the polynucleotide, used for introgressing genes into grass plants, so as to provide desirable drought resistant cultivars of plants
06/29/2010US7745601 Nucleic acids encoding T2R, a novel family of taste receptors
06/29/2010US7745600 a polynucleotide comprising a nucleotide sequence that codes for a sodium channel protein having an amino acid sequence in which one or more amino acids differs from the amino acids in the wild-type protein by replacements, used for screening compounds for use as antiarrhythmic agents
06/29/2010US7745599 Hexose oxidase-encoding DNAs and methods of use thereof
06/29/2010US7745597 TRPC6 involved in glomerulonephritis
06/29/2010US7745596 Nuclear transport nucleic acid delivery vector
06/29/2010US7745595 Compositions and methods for detecting Atopobium vaginae
06/29/2010US7745594 Nucleic acid-based logic circuits
06/29/2010US7745593 Feline CTLA-4 nucleic acid and polypeptides
06/29/2010US7745592 Expression vector comprising cumate-inducible regulatory switch for use in gene transfer; TATA elements; bioassays; genomics and gene therapy; trangenic animals; host cells
06/29/2010US7745591 phosphinocarboxylate and phosphonocarboxylate oligonucleotides having enhanced nuclease resistance
06/29/2010US7745586 antiidiotypic, chimeric, humanized, monoclonal or polyclonal antibodies or faragments that specifically binds polypeptides having synthetase enzyme activity
06/29/2010US7745576 Polypeptides having antimicrobial activity and polynucleotides encoding same
06/29/2010US7745420 stability, high effectiveness and low toxicity; for treating pulmonary/respiratory diseases such as cystic fibrosis, asthma, chronic bronchitis, chronic obstructive lung disease, eosinophilic bronchitis
06/29/2010US7745419 Short interfering RNAs (siRNA) against Wnt1; anticancer; drug delivery system of cationic liposome or cationic polymer
06/29/2010US7745418 Compositions and methods for inhibiting viral replication
06/29/2010US7745417 1,2-dihydro-2-pyridinone substituted with biotin, bromine or iodine photoreactive group, fluorescent molecule; artificial base pairs; aptamers, antisense agents, ribozymes
06/29/2010US7745408 Method of inducing melanogenesis in humans with MC1R variant alleles
06/29/2010US7745389 Factor H gene polymorphisms and haplotypes; complement inhibitors
06/29/2010US7745218 developing novel strains containing deletions of specific chromosome sites, using transposon and cre recombinase/locus of crossover in P1(loxP) site-specific recombination by Cre gene expression from a Cre genetic vector; genetic engineering
06/29/2010US7745213 nucleotide sequences coding potassium chanel protein for use in identifying modulator for prevention and treatment of cardiovascular/myocardial disorders; utilized to diagnose and screen for short QT syndrome, long QT syndrome, Brugada syndrome and progressive conduction disease
06/29/2010US7745193 recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine beta -lactamase protein
06/29/2010US7745190 Endoribonuclease
06/29/2010US7745189 encodes a cotA polypeptide having serine/threonine kinase activity ; modulation of genes associated with hyphal growth in filamentous fungi
06/29/2010US7745188 Heat resistant and error-prone polymerase for use as mutational tool in genetic analysis
06/29/2010US7745186 Ribulose, 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides
06/29/2010US7745184 Using transgenic escherichia expressing galactose-proton symporter and reduced glycerolaldehyde 3-phosphate dehydrogenase as bioreactor for 1,3-propanediol production
06/29/2010US7745180 removing erythrocytes and blood components other than leukocytes from the whole blood by filtration, then lysing leukocytes of the whole blood, and quantifying the specific mRNA in the lysate; leukocyte filters attached to oligo(dT)-immobilized multi-well plates; use in diagnosis, blood bank screening
06/29/2010US7745178 Complexity management of genomic DNA
06/29/2010US7745177 using a xylitol dehydrogenase-deficient mutant of xylitol producing microorganism; achieved through modification of the metabolic pathway of the xylitol producing microorganism, preferably a natural xylose-assimilating yeasts and fungi, by disrupting or inactivating the expression of desired genes
06/29/2010US7745175 Protective antigen for immunizing birds against necrotic enteritis
06/29/2010US7745132 Prognostic indicators of canine lymphoid neoplasia using tumor-derived plasma DNA
06/29/2010US7745131 High throughput genome specific molecular markers for erucic acid content genes in Brassica napus